Cancer treatment may inhibit immune response to COVID-19 vaccination

JACKSONVILLE, Fla. — A study by researchers at Mayo Clinic Cancer Center has found that patients with cancer who receive chemotherapy ― and some targeted therapies, such as CDK4/6 inhibitors and therapies targeted at B cells ― may mount an inadequate immune response to COVID-19 vaccination. The findings are publ ished in Mayo Clinic Proceedings: Innovation, Quality& Outcomes. "It is important for patients with cancer who are receiving chemotherapy to receive a COVID-19 vaccine," says…
Source: Mayo Clinic Arizona News - Category: Hospital Management Source Type: news